JP2017511350A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017511350A5 JP2017511350A5 JP2016562508A JP2016562508A JP2017511350A5 JP 2017511350 A5 JP2017511350 A5 JP 2017511350A5 JP 2016562508 A JP2016562508 A JP 2016562508A JP 2016562508 A JP2016562508 A JP 2016562508A JP 2017511350 A5 JP2017511350 A5 JP 2017511350A5
- Authority
- JP
- Japan
- Prior art keywords
- sitagliptin
- dosage form
- tannate complex
- oral dosage
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461980641P | 2014-04-17 | 2014-04-17 | |
| US61/980,641 | 2014-04-17 | ||
| PCT/US2015/025504 WO2015160678A1 (en) | 2014-04-17 | 2015-04-13 | Sitagliptin tannate complex |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017511350A JP2017511350A (ja) | 2017-04-20 |
| JP2017511350A5 true JP2017511350A5 (cg-RX-API-DMAC7.html) | 2017-11-24 |
| JP6523328B2 JP6523328B2 (ja) | 2019-05-29 |
Family
ID=54324454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016562508A Active JP6523328B2 (ja) | 2014-04-17 | 2015-04-13 | タンニン酸シタグリプチン複合体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9833463B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3131631B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6523328B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102351813B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN106456998B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015247921B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112016023839A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2945681A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2932383T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX374598B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2696588C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015160678A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201818969A (zh) * | 2016-10-19 | 2018-06-01 | 日商帝化製藥股份有限公司 | 在生體內之藥物溶出控制用組成物 |
| US11096890B2 (en) | 2017-09-29 | 2021-08-24 | Merck Sharp & Dohme Corp. | Chewable dosage forms containing sitagliptin and metformin |
| WO2025090920A1 (en) * | 2023-10-25 | 2025-05-01 | Piton Therapeutics, Inc. | Compositions and methods for treating dysfunction of glucose metabolism and/or regulation |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997028149A1 (en) | 1996-02-02 | 1997-08-07 | Merck & Co., Inc. | Method for raising hdl cholesterol levels |
| US5663415A (en) | 1996-06-28 | 1997-09-02 | Jame Fine Chemicals, Inc. | Process for preparing antihistamine tannates |
| AR008789A1 (es) | 1996-07-31 | 2000-02-23 | Bayer Corp | Piridinas y bifenilos substituidos |
| US6613942B1 (en) | 1997-07-01 | 2003-09-02 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
| JP2003514508A (ja) | 1997-07-01 | 2003-04-15 | ノボ ノルディスク アクティーゼルスカブ | グルカゴン拮抗剤／逆作用剤 |
| AU3033500A (en) | 1999-01-15 | 2000-08-01 | Agouron Pharmaceuticals, Inc. | Non-peptide glp-1 agonists |
| CN1356977A (zh) | 1999-05-17 | 2002-07-03 | 诺沃挪第克公司 | 胰高血糖素拮抗剂/反向激动剂 |
| WO2001023420A2 (en) | 1999-09-28 | 2001-04-05 | Bayer Corporation | Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use |
| WO2002100851A2 (en) | 2001-06-11 | 2002-12-19 | Shire Biochem Inc. | Thiophene derivatives as antiviral agents for flavivirus infection |
| UA74912C2 (en) * | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| US20030083354A1 (en) | 2001-10-26 | 2003-05-01 | Pediamed Pharmaceuticals, Inc. | Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions |
| US20030114535A1 (en) | 2001-12-14 | 2003-06-19 | Jame Fine Chemicals, Inc. | Dextrochlorpheniramine tannate |
| US6670370B1 (en) | 2001-12-14 | 2003-12-30 | Jame Fine Chemicals, Inc. | Dextromethorphan tannate |
| JO2625B1 (en) * | 2003-06-24 | 2011-11-01 | ميرك شارب اند دوم كوربوريشن | Phosphoric acid salts of dipeptidyl betidase inhibitor 4 |
| AU2004268024B2 (en) | 2003-09-02 | 2007-07-12 | Merck Sharp & Dohme Llc | Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor |
| US20070021430A1 (en) | 2003-09-23 | 2007-01-25 | Chen Alex M | Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| WO2005072530A1 (en) | 2004-01-16 | 2005-08-11 | Merck & Co., Inc. | Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor |
| US20050202050A1 (en) | 2004-03-12 | 2005-09-15 | Kiel Jeffrey S. | Single tank process for preparing tannate liquid and semi-solid dosage forms |
| US7612072B2 (en) | 2004-09-15 | 2009-11-03 | Merck & Co., Inc. | Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor |
| US20060270722A1 (en) * | 2005-05-31 | 2006-11-30 | Thornberry Nancy A | Combination of a dipeptidyl peptidase-IV inhibitor and a dual PPAR agonist for the treatment of diabetes and obesity |
| US20090221592A1 (en) | 2005-07-25 | 2009-09-03 | Ellison Martha E | Dodecylsulfate Salt Of A Dipeptidyl Peptidase-Iv Inhibitor |
| WO2007050485A2 (en) * | 2005-10-25 | 2007-05-03 | Merck & Co., Inc. | Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension |
| CA2672452C (en) * | 2006-12-14 | 2012-07-03 | Teva Pharmaceutical Industries Ltd. | Tannate salt of rasagiline |
| EP2231191A2 (en) | 2007-12-11 | 2010-09-29 | ConjuChem Biotechnologies Inc. | Formulation of insulinotropic peptide conjugates |
| US8003672B2 (en) * | 2008-04-21 | 2011-08-23 | Merck Sharp & Dohme Corp. | CB-1 receptor modulator formulations |
| EP2218721A1 (en) * | 2009-02-11 | 2010-08-18 | LEK Pharmaceuticals d.d. | Novel salts of sitagliptin |
| US9211263B2 (en) | 2012-01-06 | 2015-12-15 | Elcelyx Therapeutics, Inc. | Compositions and methods of treating metabolic disorders |
-
2015
- 2015-04-13 MX MX2016013588A patent/MX374598B/es active IP Right Grant
- 2015-04-13 US US15/302,211 patent/US9833463B2/en active Active
- 2015-04-13 BR BR112016023839A patent/BR112016023839A8/pt not_active Application Discontinuation
- 2015-04-13 EP EP15780045.9A patent/EP3131631B1/en active Active
- 2015-04-13 ES ES15780045T patent/ES2932383T3/es active Active
- 2015-04-13 AU AU2015247921A patent/AU2015247921B2/en active Active
- 2015-04-13 CA CA2945681A patent/CA2945681A1/en not_active Abandoned
- 2015-04-13 CN CN201580020211.4A patent/CN106456998B/zh active Active
- 2015-04-13 WO PCT/US2015/025504 patent/WO2015160678A1/en not_active Ceased
- 2015-04-13 JP JP2016562508A patent/JP6523328B2/ja active Active
- 2015-04-13 RU RU2016144695A patent/RU2696588C2/ru active
- 2015-04-13 KR KR1020167028345A patent/KR102351813B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2560693C2 (ru) | Быстро растворяющиеся системы, освобождающие лекарственные препараты | |
| JP2011509295A5 (cg-RX-API-DMAC7.html) | ||
| WO2011079239A3 (en) | Combination tablet with chewable outer layer | |
| JP2005507400A5 (cg-RX-API-DMAC7.html) | ||
| JP2013511507A5 (cg-RX-API-DMAC7.html) | ||
| JP2009536147A5 (cg-RX-API-DMAC7.html) | ||
| JP2014198723A5 (cg-RX-API-DMAC7.html) | ||
| JP2012533565A5 (cg-RX-API-DMAC7.html) | ||
| TW200815048A (en) | Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies | |
| US20110237563A1 (en) | Fast dissolving drug delivery systems | |
| JP2016164165A5 (cg-RX-API-DMAC7.html) | ||
| FI3710000T3 (fi) | Tradipitantti käytettäväksi gastropareesin hoidossa | |
| FI3746126T3 (fi) | Menetelmiä ja koostumuksia uniapnean tai pelkän kuorsauksen hoitamiseksi | |
| JP2009501801A5 (cg-RX-API-DMAC7.html) | ||
| JP2014221827A5 (cg-RX-API-DMAC7.html) | ||
| JP2019218379A5 (cg-RX-API-DMAC7.html) | ||
| BR112019027286A2 (pt) | formulação de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva | |
| JP2013536837A5 (cg-RX-API-DMAC7.html) | ||
| JP2010511039A5 (cg-RX-API-DMAC7.html) | ||
| JP2017511350A5 (cg-RX-API-DMAC7.html) | ||
| JP2012505830A5 (cg-RX-API-DMAC7.html) | ||
| RU2016144695A (ru) | Комплекс танната ситаглиптина | |
| CA2648538A1 (en) | Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles | |
| JP7724579B2 (ja) | 咽頭反射の処置のための組成物および治療 | |
| ZA202405485B (en) | Solid oral dosage forms of rabeprazole |